Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 July 2008, Vol. 112, No. 2, pp. 383-393.
Prepublished online as a Blood First Edition Paper on May 8, 2008; DOI 10.1182/blood-2008-01-131185.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods and Tables
Right arrow Supplemental Tables and Supplemental Figures
Right arrow All Versions of this Article:
blood-2008-01-131185v1
112/2/383    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hidaka, T.
Right arrow Articles by Morishita, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hidaka, T.
Right arrow Articles by Morishita, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma

Tomonori Hidaka1,2,*, Shingo Nakahata1,*, Kinta Hatakeyama3,*, Makoto Hamasaki1,4, Kiyoshi Yamashita2, Takashi Kohno5, Yasuhito Arai6, Tomohiko Taki7, Kazuhiro Nishida7, Akihiko Okayama8, Yujiro Asada3, Ryoji Yamaguchi9, Hirohito Tsubouchi2,10, Jun Yokota5, Masafumi Taniwaki7, Yujiro Higashi11, and Kazuhiro Morishita1

1 Division of Tumor and Cellular Biochemistry, Department of Medical Sciences, 2 Department of Internal Medicine II, University of Miyazaki, Miyazaki; 3 First Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki; 4 Miyazaki Prefectural Industrial Foundation, Miyazaki; 5 Biology Division, National Cancer Center Research Institute, Tokyo; 6 Cancer Genome Project, National Cancer Center Research Institute, Tokyo; 7 Department of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto; 8 Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki; 9 Department of Veterinary Pathology, University of Miyazaki, Miyazaki; 10 Department of Digestive and Life-style related Disease, Kagoshima University Graduate School of Medicine and Dental Sciences, Kagoshima; and 11 Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan

Adult T-cell leukemia/lymphoma (ATLL) is caused by latent human T-lymphotropic virus-1 (HTLV-1) infection. To clarify the molecular mechanism underlying leukemogenesis after viral infection, we precisely mapped 605 chromosomal breakpoints in 61 ATLL cases by spectral karyotyping and identified frequent chromosomal breakpoints in 10p11, 14q11, and 14q32. Single nucleotide polymorphism (SNP) array–comparative genomic hybridization (CGH), genetic, and expression analyses of the genes mapped within a common breakpoint cluster region in 10p11.2 revealed that in ATLL cells, transcription factor 8 (TCF8) was frequently disrupted by several mechanisms, including mainly epigenetic dysregulation. TCF8 mutant mice frequently developed invasive CD4+ T-cell lymphomas in the thymus or in ascitic fluid in vivo. Down-regulation of TCF8 expression in ATLL cells in vitro was associated with resistance to transforming growth factor β1 (TGF-β1), a well-known characteristic of ATLL cells, suggesting that escape from TGF-β1–mediated growth inhibition is important in the pathogenesis of ATLL. These findings indicate that TCF8 has a tumor suppressor role in ATLL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020